Little Green Pharma cannabis medicines are available for prescribers to access as a treatment option through the TGA’s Special Access Scheme (SAS).
All Little Green Pharma medicines comply with the strict Australian Therapeutic Goods (Standard for Medicinal Cannabis) (TGO 93) Order 2017 and are grown and manufactured in GMP facilities located in Australia and Denmark.
Our medical cannabis preparations provide various THC and CBD profiles and are available to prescribe in the dosage form of medicinal cannabis oils and dried cannabis flower.
The LGP product range
Please note: The purpose of this webpage is to educate and inform healthcare professionals about Little Green Pharma products. Our products are non-ARTG (unregistered) and available under the Special Access Scheme (SAS).
Little Green Pharma can arrange the supply of the following products with an approved prescription obtained via Special Access Scheme or Authorised Prescriber applications.
Little Green Pharma has implemented three colours to assist medical practitioners to identify the ratio of cannabinoids THC and CBD in our products. The THC dominant products are represented by orange, THC/CBD balance (equal ratio) by green and CBD dominant represented by blue.
Want to know more about our cannabis medicines?
For information on steps to accessing medical cannabis in Australia, you can download the Simple Steps to Access Guide here